Eye Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-05-06 AMPE NR7 Range Contraction
2021-05-06 AMPE Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 AMPE Hammer Candlestick Bullish
2021-05-06 AMPE Fell Below 20 DMA Bearish
2021-05-06 AMPE 50 DMA Support Bullish
2021-05-06 EYPT Expansion Pivot Sell Setup Bearish Swing Setup
2021-05-06 EYPT Fell Below 20 DMA Bearish
2021-05-06 EYPT Fell Below 50 DMA Bearish
2021-05-06 IMVT NR7 Range Contraction
2021-05-06 IMVT Upper Bollinger Band Walk Strength
2021-05-06 IMVT Bollinger Band Squeeze Range Contraction
2021-05-06 IRIX 20 DMA Resistance Bearish
2021-05-06 IRIX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 IRIX 1,2,3 Pullback Bullish Bullish Swing Setup
2021-05-06 OCGN Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 OCGN 1,2,3 Pullback Bullish Bullish Swing Setup
2021-05-06 OCGN Doji - Bullish? Reversal
2021-05-06 OCGN Calm After Storm Range Contraction
2021-05-06 OCGN 20 DMA Support Bullish
2021-05-06 OCUL Fell Below 20 DMA Bearish
2021-05-06 OPT Narrow Range Bar Range Contraction
2021-05-06 OYST New 52 Week Low Weakness
2021-05-06 OYST Hammer Candlestick Bullish
2021-05-06 OYST Lower Bollinger Band Walk Weakness
2021-05-06 SCYX MACD Bearish Signal Line Cross Bearish
2021-05-06 SCYX Stochastic Reached Oversold Weakness

Recent News for Eye Disease Stocks

Date Stock Title
May 6 OYST Oyster Point Pharma EPS beats by $0.18
May 6 OYST Oyster Point Pharma Reports First Quarter 2021 Financial Results and Recent Business Highlights
May 6 OCGN BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues
May 6 OCGN Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study
May 6 OCUL Ocular Therapeutix: Catalysts Stacking
May 6 OCGN Ocugen shares fall 14% despite OCU200 shows potential to treat ocular neovascular diseases
May 6 OYST New Strong Sell Stocks for May 6th
May 6 OCGN Drug/Biotech Stock Q1 Earnings on May 7: RDUS, CRON & OCGN
May 6 AGTC Applied Genetic's XLRP Gene Therapy Shows Improved, Durable Response In Retinal Sensitivity
May 6 OCGN Ocugen Presents New Preclinical OCU200 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
May 6 AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial
May 6 OCUL Ocular Therapeutix's (OCUL) CEO Antony Mattessich on Q1 2021 Results - Earnings Call Transcript
May 5 AGTC AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Groups and 24-Month Data from a Subset of Group 4 Patients of its Ongoing Phase 1/2 Clinical Trial
May 5 OCUL Ocular Therapeutix EPS misses by $0.04, misses on revenue
May 5 AMPE Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business Update
May 5 OCUL Ocular Therapeutix™ Reports First Quarter 2021 Financial Results and Business Update
May 5 EYPT EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call Transcript
May 5 OCGN Stocks To Watch This Week: 4 Health Care Stocks To Know
May 5 EYPT EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue Estimates
May 5 AGTC Editas strengthens Q1 liquidity despite rising net loss; names new chief scientific officer